Search Results 1371-1380 of 16310 for Phantom%2Blimb

  1. Movement disorders - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  2. Movement disorders - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  3. Movement disorders - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  4. Mayo Clinic

    ... . IMG-20038031. Home; gamma-knife-2coljpg. Fuel groundbreaking medical research! Give Today. Your donation powers the future of medicine and helps save ...

  5. Movement disorders - Doctors and departments - Mayo Clinic

    Learn about the different types of neurological conditions that affect movement.

  6. Movement disorders - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  7. Movement disorders - Doctors and departments - Mayo Clinic

    Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in Arizona, ...

  8. Gastroenterology and Hepatology - Clinical trials

    Rochester, Minn. The purpose of this study is to create a registry of obese patients who have been phenotyped to understand the heterogeneity of obesity. Celiac ...

  9. Movement disorders - Doctors and departments - Mayo Clinic

    Learn about the different types of neurological conditions that affect movement.

  10. A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma - Mayo Clinic

    About this study. The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + ...